The role of transferrin in iron delivery to tissues is described. Transferrin-dependent iron uptake by erythroid cells in the bone marrow is essential for the development of erythrocytes, while nontransferrin-bound iron can be taken up in tissues such as liver. On the basis of the evidence that iron distribution in the body is changed by iron saturation of plasma transferrin, the role of transferrin in iron delivery to the brain is reviewed. In the case of transient iron saturation of plasma transferrin, 59 Fe concentrations in the brain of iron-loaded mice are approximately 40-50% of those of control mice in all brain regions tested except the choroid plexus, in which the 59 Fe concentration is equal. A similar distribution of 59 Fe in the brain is also observed in neonatal hypotransferrinemic (HP) mice, which have a splicing defect in the transferrin gene, resulting in < 1% of the normal plasma levels of transferrin. These results suggest that transferrin-bound iron is responsible for the fraction of iron in the circulation that enters the brain. On the other hand, the iron concentration in the brain of HP mice is approximately three times higher than that in nonmutant mice. It is likely that the management of iron is affected in the brain of HP mice. Brain transferrin may be involved in the management of iron in the brain.
INTRODUCTION
Transferrin, a plasma glycoprotein, has been considered as an important molecule for the transport of iron. 1, 2) Transferrin-dependent iron uptake by erythroid cells in the bone marrow is essential for the development of erythrocytes. [3] [4] [5] Iron-deficient anemia is widely known in humans and animals. Transferrin is synthesized primarily in the liver, while a significant amount is also produced in the brain. [6] [7] [8] [9] [10] In the brain, transferrin mRNA exists in oligodendrocytes and also in the choroid plexus in concentrations equal to that found in liver.
Iron is essential for the development and functioning of the brain. 11, 12) Iron concentrations in the human brain are approximately five times higher in adults (approximately 65 µg/g wet weight) than in infants below 1 year of age, 13) suggesting that iron is a required component for brain functions. In the brain, iron is found in oligodendrocytes in high density and is required for myelin production. 14, 15) Iron uptake is the highest during postnatal development at a time that coincides with peaks in brain growth and myelin production, 16) and an insufficient iron supply to the brain results in hypomyelination. 17) Thus an adequate supply of iron is important for brain development. Recent evidence suggests a functional difference between transferrin synthesized in the brain and in other tissues such as liver and a specific role of transferrin in oligodendrocyte maturation and in myelinogenesis.
18)

Hemochromatosis and Hypotransferrinemia
Hereditary hemochromatosis is characterized by the triad of increased iron absorption by gastrointestinal cells, high or total iron saturation of plasma transferrin, and abnormal iron deposition in the tissues, especially in the liver. 19, 20) A similar pattern of liver iron deposition is also observed in the hypotransferrinemic (HP) mice, 21) which have a point mutation or small deletion in the transferrin gene *To whom correspondence should be addressed: Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan. Tel.: +81-54-264-5700; Fax: +81-54-264-5705; E-mail: takedaa@u-shizuoka-ken.ac.jp and produce < 1% of the normal circulating level of plasma transferrin. 22) The affected animals are small, pale, and severely anemic at birth and require weekly injections of serum or purified transferrin for survival. The liver iron deposition in the two disorders of hereditary hemochromatosis and hypotransferrinemia may be due to saturation or lack of transferrin.
Iron Distribution in the Brain under Iron Saturation of Plasma Transferrin
Craven et al. reported the tissue distribution of nontranferrin-bound 59 Fe in the case of transient saturation of plasma transferrin by intravenous injection of ferric citrate. 23) Plasma clearance of nontransferrin-bound 59 Fe is very high. In ironloaded rats, > 80% of the injected radioactivity is eliminated from the plasma by 30 s, probably owing to rapid uptake of nontransferrin-bound 59 Fe by the liver. On the basis of the evidence that tissue iron distribution is changed by iron saturation of plasma transferrin, the influence of iron saturation of transferrin in iron delivery to the brain was studied by means of brain autoradiography. 24) Twentyfour hours after intravenous injection of 59 FeCl 3 into iron-loaded mice, 59 Fe distribution in the brain was different between control and iron-loaded mice. 59 Fe concentrations in the brain of iron-loaded mice were approximately 40-50% of those of control mice in all brain regions tested except the choroid plexus, in which the 59 Fe concentration was equal. Transferrin-bound iron may be responsible for the fraction of iron in circulation that enters the brain (Fig. 1) .
Regarding iron delivery at the blood brain-barrier, two hypotheses are proposed. One hypothesis suggests that a large portion of holo-transferrin taken up by the capillary endothelial cells is recycled to the blood as apo-transferrin. Iron released from transferrin in endosomal compartments is transcytosed by unknown mechanisms. 25, 26) The other hypothesis suggests that transferrin-bound iron is transcytosed predominantly across the capillary endothelial cells. [27] [28] [29] The data showing that transferrin in the brain of adult HP mice is of exogeneous origin support the latter hypothesis. 30) In the brain in hereditary hemochromatosis, iron deposition has not been described as a pathological phenomenon and this disease is not usually associated with neurological symptoms. 31) Sotogaku et al. demonstrated that the iron concentration in the brain, unlike in the liver, only increases slightly after persistent iron overloading. 32) Therefore it is likely that nontransferrin-bound iron present in the circulation of hemochromatosis patients is of little significance as a cause of pathological iron accumulation in the brain.
Nontransferrin-Mediated Iron Transport into the Brain
Blood radioactivity of iron-loaded mice is approximately 10% of that of control mice; the decrease in 59 Fe concentration in the brain by iron loading is not parallel with that in the plasma. 24) There is the possibility that a portion of nontransferrin-bound 59 Fe is transported into the brain (Fig. 1) . p97 (melanotransferrin), an iron-binding protein, is reported to be present in brain capillary endothelium and a subset of microglial cells in humans. 33, 34) DMT1, a divalent metal transporter, which is involved in the transport of ferrous ion via a ferrireductase, is abundantly expressed in rat choroidal epithelial cells. 35) If these proteins are generally expressed in the blood-brain and/or the bloodcerebrospinal fluid (CSF) barriers of mammals, these proteins appear to be involved in iron transport into the brain across the brain barrier system in the case of iron saturation of plasma transferrin (Fig. 1) .
Judging from the concentrations of iron and transferrin in lumbar CSF from control humans, it is estimated that CSF transferrin is fully saturated with iron and that nontransferrin-bound iron is present in the CSF.
36) The presence of nontransferrin-
Fig. 1. Iron Transport into the Brain Across the Brain Barrier System
The receptor-mediated endocytosis of iron-transferrin (Fe-Tf) is important for physiological delivery of iron to the brain. The mechanism via iron transporters such as DMT1 and p97 might serve for iron delivery in the brain barrier system under iron saturation of plasma transferrin. In the brain, iron-transferrin may be taken up in neurons via receptormediated endocytosis, 51) while nontransferrin-bound iron may be taken up in glial cells. 39) R, transferrin receptor; Fe-X, nontransferrin-bound iron.
Vol. 47 (2001) bound iron in brain extracellular fluid, including CSF, was reported by Moos and Morgan 37) and Lipscomb et al. 38) Evidence for nontransferrin-mediated iron uptake is also indicated in glial cell cultures from unaffected control mice as well as HP mice.
39)
Iron Distribution in the Brain under Hypotransferrinemia
The role of transferrin in the utilization of iron in the brain was studied using 7-day-old HP mice without administration of transferrin. 40, 41) Twentyfour hours after injection of 59 FeCl 3 into HP mice, 59 Fe was highly concentrated in the choroid plexus and 59 Fe concentrations in brain parenchyma were lower than in nonmutant mice. 59 Fe distribution in the brain of HP mice is similar to the case of the transient saturation of transferrin by iron loading. 24) In the brain of adult HP mice, the cellular and regional distributions of iron, transferrin, transferrin receptor, and ferritin are similar to those in normal mice, although transferrin in the brain is of exogeneous origin. 30, 42) Interestingly, the iron concentration in the brain of 7-day-old HP mice is approximately three times higher than that in nonmutant mice.
41) The circulation of iron in the brain extracellular fluid might be impaired by the lack of transferrin, resulting in abnormal iron accumulation in the brain. It is likely that the management of iron is affected in the brain of HP mice. Brain transferrin may be involved in the management of iron in the brain.
Iron is a toxicant in excessive amounts; free iron can be cytotoxic by catalyzing the production of hydroxyl radical from hydrogen peroxide. 43) Brain transferrin levels decrease with age and its decrease is dramatic when Alzheimer's disease or Parkinson's disease is superimposed on the aging process.
44) The transferrin/iron ratio, a possible index of iron mobilization capacity, is decreased in the globus pallidus and caudate putamen in both Alzheimer's and Parkinson's diseases. The decrease in transferrin levels in neurodegenerative diseases has been suggested as the cause of increased brain iron concentrations in these diseases. [45] [46] [47] [48] [49] [50] 
Conclusion
Transferrin is important for physiological delivery of iron to the brain. Transferrin may be involved in the management of iron in the brain.
